The vocal biomarkers global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Vocal Biomarkers Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The vocal biomarkers market size has grown rapidly in recent years. It will grow from $2.4 billion in 2023 to $2.84 billion in 2024 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to the need for early detection of diseases, vocal biomarker applications in lie detection, demand for vocal biomarkers in the defense sector, increasing incidence of mental disorders, and rising chronic diseases such as cardiovascular disease.
The vocal biomarkers market size is expected to see exponential growth in the next few years. It will grow to $5.63 billion in 2028 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to rising cases of neurological and psychological disorders, high demand for novel diagnostic procedures, a growing incidence of dementia, increasing awareness about the efficacy of vocal biomarkers, and increasing diagnostic procedures. Major trends in the forecast period include advancements in biomarker technology, rapid adoption of advanced technologies, high investments in R&D, improvements in diagnostic capabilities, and advanced technology in the medical industry.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/vocal-biomarkers-global-market-report
Scope Of Vocal Biomarkers Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Vocal Biomarkers Market Overview
Market Drivers –
The rising cases of neurological and psychological disorders are expected to propel the growth of the voice biomarkers market going forward. Neurological disorders are medical conditions affecting the nervous system, whereas psychological disorders are conditions that impact mood, thinking, and behavior. The increasing cases of neurological and psychological disorders can be attributed to factors such as increased stress, aging populations, lifestyle changes, and greater awareness and diagnosis capabilities. Neurological and psychological disorders use voice biomarkers to non-invasively detect and monitor disease-specific changes in speech patterns, pitch, and rhythm, providing valuable insights into the presence and progression of these conditions. For instance, in April 2024, according to the data published by alzheimers.gov, a US-based Department of Health and Human Services (HHS), more than 6 million Americans aged 65 and older are living with Alzheimer’s disease in 2024, and it is predicted that this number will increase to more than 13 million people by 2060. Additionally, in April 2021, according to the Centers for Disease Control and Prevention, a US-based national public health agency, from August 2020 to February 2021, the percentage of adults experiencing symptoms of anxiety or depressive disorders rose from 36.4% to 41.5%. Therefore, the rising cases of neurological and psychological disorders are driving the growth of the voice biomarkers market going forward.
Market Trends –
Major companies operating in the vocal biomarkers market are focusing on developing advanced technology, such as voice-enabled technology, to enhance diagnostic accuracy, improve patient monitoring, and enable early detection of various medical conditions. Voice-enabled technology aims to help individuals better understand their mental state and encourage proactive engagement with mental health services. For instance, in October 2021, Sonde Health Inc., a US-based health technology company, launched Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology. The technology analyzes vocal features such as smoothness, control, liveliness, energy range, and clarity to detect changes that could indicate conditions such as depression, stress, anxiety, and fatigue. This demonstrates the company’s leadership in the vocal biomarker market and the growing potential for voice-based technologies to transform health monitoring and management, particularly in the critical area of mental health
The vocal biomarkers market covered in this report is segmented –
1) By Type: Frequency, Amplitude, Error Rate, Vocal Rise Or Fall Time, Phonation Time, Voice Tremor, Pitch, Other Types
2) By Indications: Psychiatric Disorders, Neurological Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Other Indications
3) By Consumer: Children And Newborns, Adult
4) By End Users: Hospitals And Clinics, Academic, Research, Other End-Users
Get an inside scoop of the vocal biomarkers market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17294&type=smp
Regional Insights –
North America was the largest region in the vocal biomarkers market in 2023. The regions covered in the vocal biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the vocal biomarkers market are Hitachi Ltd., International Business Machines Corporation, Synaptics Inc., Nuance Communications, Veritone Inc., Axios Pro, Cogito Corporation, Boston Technology Corporation, Cambridge Cognition Ltd., ConversationHealth, Beyond Verbal, AudEERING, EVOCAL Health, Sonde Health Inc., Kintsugi Health, Ellipsis Health, Canary Speech, Vocalis Health, Puretech Health, Neurotrack Technologies Inc
Table of Contents
1. Executive Summary
2. Vocal Biomarkers Market characterstics
3. Vocal Biomarkers Market Trends And Strategies
4. Vocal Biomarkers Market – Macro Economic Scenario
5. Global Vocal Biomarkers Market Size And Growth
…..
32. Global Vocal Biomarkers Market Competitive Benchmarking
33. Global Vocal Biomarkers Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Vocal Biomarkers Market
35. Vocal Biomarkers Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
